Cargando…
Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis
OBJECTIVE: This study aimed to investigate mitochondrial changes and the mitochondrial antiviral‐signaling protein (MAVS)‐type I interferon (IFN1) signaling pathway in the muscles of anti‐melanoma differentiation gene 5(MDA5) dermatomyositis (DM) patients. METHODS: Eleven anti‐MDA5 DM and ten antibo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951095/ https://www.ncbi.nlm.nih.gov/pubmed/33576578 http://dx.doi.org/10.1002/acn3.51311 |
_version_ | 1783663584254885888 |
---|---|
author | Jiang, Yanyan Liu, Yilin Zhao, Yawen Zheng, Yiming Yu, Meng Deng, Jianwen Hao, Hongjun Zhang, Wei Wang, Zhaoxia Yuan, Yun |
author_facet | Jiang, Yanyan Liu, Yilin Zhao, Yawen Zheng, Yiming Yu, Meng Deng, Jianwen Hao, Hongjun Zhang, Wei Wang, Zhaoxia Yuan, Yun |
author_sort | Jiang, Yanyan |
collection | PubMed |
description | OBJECTIVE: This study aimed to investigate mitochondrial changes and the mitochondrial antiviral‐signaling protein (MAVS)‐type I interferon (IFN1) signaling pathway in the muscles of anti‐melanoma differentiation gene 5(MDA5) dermatomyositis (DM) patients. METHODS: Eleven anti‐MDA5 DM and ten antibody‐negative DM patients were included. Muscle biopsies were performed in all patients. Muscle pathology and mitochondrial morphology in particular were compared between two groups. The expression of MDA5, MAVS, interferon (IFN) regulatory factor 7, and IFN‐stimulated gene 15, which are components of the MAVS‐IFN1 signaling pathway, was measured in muscle specimen. The correlation between MAVS expression in muscles and disease phenotypes and muscle pathology were analyzed. RESULTS: Anti‐MDA5 DM showed a significantly lower incidence of the characteristic DM pathology (P < 0.05) than antibody‐negative DM, including perifascicular fiber atrophy, inflammation, and vasculopathy. Mitochondrial abnormalities in anti‐MDA5 patients revealed a high incidence of (8/11,72.7%) and different pattern from that in antibody‐negative DM. MDA5, MAVS, IFN regulatory factor 7, and IFN stimulated gene 15 expression levels in the muscles of anti‐MDA5 DM patients were higher than those of the controls (P < 0.05) but lower than those of antibody‐negative DM patients (P < 0.05). The MAVS levels negatively correlated with manual muscle test 8 scores (r = 0.701, P = 0.016). CONCLUSIONS: Compared to antibody‐negative DM, we presented a different distribution of the mitochondrial pathology and less severe morphology in anti‐MDA5 DM. We also revealed the enhanced but less intensive MAVS‐IFN1 signaling pathway activity in muscles of anti‐MDA5 DM. Such disparity suggested the potentially different mechanism of muscle injury in two DM groups. |
format | Online Article Text |
id | pubmed-7951095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79510952021-03-17 Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis Jiang, Yanyan Liu, Yilin Zhao, Yawen Zheng, Yiming Yu, Meng Deng, Jianwen Hao, Hongjun Zhang, Wei Wang, Zhaoxia Yuan, Yun Ann Clin Transl Neurol Research Articles OBJECTIVE: This study aimed to investigate mitochondrial changes and the mitochondrial antiviral‐signaling protein (MAVS)‐type I interferon (IFN1) signaling pathway in the muscles of anti‐melanoma differentiation gene 5(MDA5) dermatomyositis (DM) patients. METHODS: Eleven anti‐MDA5 DM and ten antibody‐negative DM patients were included. Muscle biopsies were performed in all patients. Muscle pathology and mitochondrial morphology in particular were compared between two groups. The expression of MDA5, MAVS, interferon (IFN) regulatory factor 7, and IFN‐stimulated gene 15, which are components of the MAVS‐IFN1 signaling pathway, was measured in muscle specimen. The correlation between MAVS expression in muscles and disease phenotypes and muscle pathology were analyzed. RESULTS: Anti‐MDA5 DM showed a significantly lower incidence of the characteristic DM pathology (P < 0.05) than antibody‐negative DM, including perifascicular fiber atrophy, inflammation, and vasculopathy. Mitochondrial abnormalities in anti‐MDA5 patients revealed a high incidence of (8/11,72.7%) and different pattern from that in antibody‐negative DM. MDA5, MAVS, IFN regulatory factor 7, and IFN stimulated gene 15 expression levels in the muscles of anti‐MDA5 DM patients were higher than those of the controls (P < 0.05) but lower than those of antibody‐negative DM patients (P < 0.05). The MAVS levels negatively correlated with manual muscle test 8 scores (r = 0.701, P = 0.016). CONCLUSIONS: Compared to antibody‐negative DM, we presented a different distribution of the mitochondrial pathology and less severe morphology in anti‐MDA5 DM. We also revealed the enhanced but less intensive MAVS‐IFN1 signaling pathway activity in muscles of anti‐MDA5 DM. Such disparity suggested the potentially different mechanism of muscle injury in two DM groups. John Wiley and Sons Inc. 2021-02-12 /pmc/articles/PMC7951095/ /pubmed/33576578 http://dx.doi.org/10.1002/acn3.51311 Text en © 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Jiang, Yanyan Liu, Yilin Zhao, Yawen Zheng, Yiming Yu, Meng Deng, Jianwen Hao, Hongjun Zhang, Wei Wang, Zhaoxia Yuan, Yun Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis |
title | Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis |
title_full | Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis |
title_fullStr | Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis |
title_full_unstemmed | Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis |
title_short | Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis |
title_sort | mitochondrial morphology and mavs‐ifn1 signaling pathway in muscles of anti‐mda5 dermatomyositis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951095/ https://www.ncbi.nlm.nih.gov/pubmed/33576578 http://dx.doi.org/10.1002/acn3.51311 |
work_keys_str_mv | AT jiangyanyan mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis AT liuyilin mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis AT zhaoyawen mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis AT zhengyiming mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis AT yumeng mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis AT dengjianwen mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis AT haohongjun mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis AT zhangwei mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis AT wangzhaoxia mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis AT yuanyun mitochondrialmorphologyandmavsifn1signalingpathwayinmusclesofantimda5dermatomyositis |